
Rare Neurological Disease Market Poised to Double by 2036
The global market for rare neurological disease treatments is set to surge from 21.5 billion dollars in 2026 to 43.7 billion by 2036. This growth, forecasted at a compound annual rate of 7.4 percent, reflects a fundamental shift in medicine from managing symptoms toward targeted genetic and biological interventions.



























